Technology Overview　AC-05
Technology	Novel VEGFR-3 Antagonists for Cancer Treatment
Mechanism	Inhibition of VEGF Receptor 3 activity which leads to inhibit tumor growth by anti-angiogenesis and anti-metastasis
Indication	Small molecule agents for cancer treatment
Efficacy	In vitro	Non-cytotoxic agent High specificity to VEGF receptor 3
	In vivo	Inhibition of lung cancer metastasis on mice model
Development Stage	Lead Optimization, Formulation
Intellectual Property	US Patent Pending (11/949,070@2007/12/3), PCT Patent Pending (PCT/US07/86220), TW Patent Pending (96,146,086@2007/12/4)
Collaboration Opportunity	Technology licensing, Co-development, Research collaboration